Search details
1.
Caregiver-reported quality of communication in pancreatic and periampullary cancer.
Cancer
; 130(11): 2051-2059, 2024 Jun 01.
Article
in English
| MEDLINE | ID: mdl-38146683
2.
Predictors of Financial Toxicity Risk Among Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC).
Ann Surg Oncol
; 31(3): 1980-1989, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38044348
3.
Adoption of an Enhanced Recovery After Surgery Protocol Increases Cost of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy and Does not Improve Outcomes.
Ann Surg Oncol
; 2024 May 22.
Article
in English
| MEDLINE | ID: mdl-38777898
4.
Intra- and Interpatient Drug Response Heterogeneity Exist in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Nongynecologic Cancers.
Ann Surg Oncol
; 31(3): 1996-2007, 2024 Mar.
Article
in English
| MEDLINE | ID: mdl-38175427
5.
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC Collaborative.
Ann Surg Oncol
; 31(5): 3314-3324, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38310181
6.
Neighborhood-Level Socioeconomic Disadvantage Predicts Outcomes in Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Malignancy.
Ann Surg Oncol
; 30(12): 7840-7847, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37620532
7.
Tumor deposits are associated with a higher risk of peritoneal disease in non-metastatic colorectal cancer patients.
J Surg Oncol
; 127(6): 975-982, 2023 May.
Article
in English
| MEDLINE | ID: mdl-36790093
8.
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPEC.
J Surg Oncol
; 127(4): 706-715, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36468401
9.
Feasibility of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced peritoneal surface tumors during the COVID-19 pandemic: A single-institution experience.
J Surg Oncol
; 126(8): 1375-1382, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36081374
10.
Management of Low-Grade Appendiceal Mucinous Neoplasms (LAMN): An International Survey of Surgeons Performing CRS and HIPEC.
Ann Surg Oncol
; 28(7): 3831-3837, 2021 Jul.
Article
in English
| MEDLINE | ID: mdl-33393023
11.
Impact of Perioperative Blood Transfusions on Outcomes After Hyperthermic Intraperitoneal Chemotherapy: A Propensity-Matched Analysis.
Ann Surg Oncol
; 28(8): 4499-4507, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33507449
12.
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPEC.
Ann Surg Oncol
; 27(13): 4894-4907, 2020 Dec.
Article
in English
| MEDLINE | ID: mdl-32378087
13.
Predictors of Non-home Discharge after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
J Surg Res
; 255: 475-485, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32622162
14.
ASO Author Reflections: Financial Toxicity and CRS-HIPEC-Is a Pound of Debt Worth an Ounce of Cure?
Ann Surg Oncol
; 31(4): 2401-2402, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38087135
15.
ASO Author Reflections: To Test or Not to Test: How Do We Decide the Optimal Site for Organoid Generation in Patients with Metastatic Disease?
Ann Surg Oncol
; 31(4): 2403-2404, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-38243125
16.
ASO Author Reflections: One Size Does Not Fit All-Enhanced Recovery After Surgery in CRS-HIPEC.
Ann Surg Oncol
; 2024 May 24.
Article
in English
| MEDLINE | ID: mdl-38789616
17.
Primary Tumor Sidedness is Predictive of Survival in Colon Cancer Patients Treated with Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy: A US HIPEC Collaborative Study.
Ann Surg Oncol
; 26(7): 2234-2240, 2019 Jul.
Article
in English
| MEDLINE | ID: mdl-31016486
18.
Non-operative management of rectal cancer.
Semin Colon Rectal Surg
; 30(2): 79-84, 2019 Jun.
Article
in English
| MEDLINE | ID: mdl-32818013
19.
Less Than Ten: Defining the Role of Splenic Hilar Lymph Node Dissection in Gastric Cancer.
Ann Surg Oncol
; 30(7): 3869-3870, 2023 07.
Article
in English
| MEDLINE | ID: mdl-36976408
20.
ASO Author Reflections: Closing the Gap: A Call to Action to Improve Access and Outcomes of Peritoneal Surface Malignancy Care.
Ann Surg Oncol
; 30(12): 7863-7864, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37620536